IVDs are widely used to diagnose, monitor, and assess medical
conditions, diseases, or infections usually in a controlled environment.
IVD tests provide outcomes for earlier and more targeted treatment.
These tests are minimally invasive, help reduce hospital stay, and
provide accurate results. This kind of diagnostics provides early
detection of diseases and thereby helps better control and curb the
burden of diseases across the world.
Analysts forecast the Global IVD market will grow at a CAGR of 6.86 percent over the period 2013-2018.
The
Repoer recognizes the following companies as the key players in Global
IVD Market: Abbott Laboratories, Johnson & Johnson, Roche
Diagnostics Inc., Siemens Healthcare, 23andMe, A. Menarini Diagnostics,
Affymetrix, Agilent Technologies, Alere, ARKRAY, Axis-Shield , Bio-Rad
Laboratories, Bruker BioSciences, Celera Diagnostics , Cepheid, China
Medical Technologies, Dako , DiaSorin , Eiken Chemical , ELITech ,
Fujirebio Diagnostics, GE Healthcare, Grifols , Horiba, Illumina,
Instrumentation Laboratory, IRIS International, Luminex, Magellan
Biosciences, Nanosphere, Nova Biomedical, Nova Century Scientific,
Novartis , PerkinElmer, Phadia , QIAGEN , Quidel, Randox Laboratories,
Sequenom, Shenzhen Mindray Bio-Medical Electronics , Siemens
Healthcare, Spartan Bioscience , Sysmex, Thermo Fisher Scientific ,
Tosoh , Transasia Bio-Medicals , Trinity Biotech , Ventana Medical
Systems , Veridex , Wako Pure Chemical Industries , Werfen Life Group
In
the recent past, there has been an increased adoption of POC diagnostic
tests by patients. This is because these tests provide rapid results
and help influence treatment decisions immediately. This, in turn,
reduces the length of patient stays in hospitals and backlogs in areas
such as emergency departments where patients have to wait for test
results. Currently, POC tests are available for blood glucose testing,
pregnancy testing, hemoglobin testing, rapid coagulation testing,
cardiac markers diagnostics, blood gas, electrolytes analysis, urine
testing, fecal occult blood analysis, food pathogens screening,
infectious disease testing, and cholesterol screening. Among these,
pregnancy tests and blood glucose testing are the most commonly used POC
diagnostic tests. Hence, the increased adoption of POC diagnostic tests
is expected to increase the growth of the market during the forecast
period.
Covered in this Report
The Global
IVD market can be categorized on the basis of type of test into the
following segments: POC, Core Laboratory, Molecular, Hematology,
Coagulation, Microbiology, Blood Banking, and Histology/Cytology.
Global
IVD Market 2014-2018, has been prepared based on an in-depth market
analysis with inputs from industry experts. The report covers the
Americas and the EMEA and APAC regions; it also covers the Global IVD
market landscape and its growth prospects in the coming years. The
report also includes a discussion of the key vendors operating in this
market.
According to the report, one of the major drivers in this
market is the rapid increase in the aging population across the world.
The aging population is at a greater risk of acquiring chronic diseases
and infections, which has fostered the demand for rapid MI and
non-invasive IVD testing. This, in turn, has increased the volume of
diagnostic laboratory tests being performed across the world.
Further,
the report states that one of the major challenges is the issues in the
regulatory framework for IVD products. Improper and stringent
regulations by the FDA and regulatory authorities in the EU for certain
IVD tests are hindering the adoption of these tests.
